These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9328574)

  • 21. Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3.
    Ritter G; Boosfeld E; Markstein E; Yu RK; Ren SL; Stallcup WB; Oettgen HF; Old LJ; Livingston PO
    Cancer Res; 1990 Mar; 50(5):1403-10. PubMed ID: 2302705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis.
    Kanazawa J; Ohta S; Shitara K; Fujita F; Fujita M; Hanai N; Akinaga S; Okabe M
    Cancer Immunol Immunother; 2000 Jul; 49(4-5):253-8. PubMed ID: 10941908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
    Ragupathi G; Meyers M; Adluri S; Howard L; Musselli C; Livingston PO
    Int J Cancer; 2000 Mar; 85(5):659-66. PubMed ID: 10699946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglioside conjugate vaccines. Immunotherapy against tumors of neuroectodermal origin.
    Helling F; Livingston PO
    Mol Chem Neuropathol; 1994; 21(2-3):299-309. PubMed ID: 8086040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.
    McCaffery M; Yao TJ; Williams L; Livingston PO; Houghton AN; Chapman PB
    Clin Cancer Res; 1996 Apr; 2(4):679-86. PubMed ID: 9816218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3.
    Ren S; Ariga T; Scarsdale JN; Zhang Y; Slominski A; Livingston PO; Ritter G; Kushi Y; Yu RK
    J Lipid Res; 1993 Sep; 34(9):1565-72. PubMed ID: 8228639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of exogenously added gangliosides in serum proteins depends on the relative affinity of albumin and lipoproteins.
    Rebbaa A; Portoukalian J
    J Lipid Res; 1995 Mar; 36(3):564-72. PubMed ID: 7775868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.
    Yao TJ; Meyers M; Livingston PO; Houghton AN; Chapman PB
    Clin Cancer Res; 1999 Jan; 5(1):77-81. PubMed ID: 9918205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
    Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
    J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganglioside profiles of experimental melanomas and of their melanosomal fractions.
    Vedralová E; Borovanský J; Hach P
    Melanoma Res; 1995 Apr; 5(2):87-92. PubMed ID: 7620344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
    Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
    J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic and spatial interrelationships between ganglioside glycosyltransferases and O-acetyltransferase(s) in human melanoma cells.
    Sjoberg ER; Varki A
    J Biol Chem; 1993 May; 268(14):10185-96. PubMed ID: 8486686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. EORTC Cooperative Melanoma Group.
    Portoukalian J; Carrel S; Doré JF; Rümke P
    Int J Cancer; 1991 Dec; 49(6):893-9. PubMed ID: 1959994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
    Hersey P
    Cancer Treat Res; 1991; 54():137-51. PubMed ID: 1673856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma-associated gangliosides in the fish genus Xiphophorus.
    Felding-Habermann B; Anders A; Dippold WG; Stallcup WB; Wiegandt H
    Cancer Res; 1988 Jun; 48(12):3454-60. PubMed ID: 3370642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma.
    Ramos AS; Parise CB; Travassos LR; Han SW; de Campos-Lima PO; de Moraes JZ
    Cancer Sci; 2011 Jan; 102(1):64-70. PubMed ID: 21070480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of shed human tumor gangliosides: association with serum lipoproteins.
    Valentino LA; Ladisch S
    Cancer Res; 1992 Feb; 52(4):810-4. PubMed ID: 1737341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant.
    Cheresh DA; Reisfeld RA; Varki AP
    Science; 1984 Aug; 225(4664):844-6. PubMed ID: 6206564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2.
    Hoon DS; Irie RF; Cochran AJ
    Cell Immunol; 1988 Feb; 111(2):410-9. PubMed ID: 3123073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.